Skip to main content

Table 3 Percentage gene expression of mEC-specific genes expressed in primary versus recurrent tumor samples (Group A expressed similarly in primary and recurrent samples).

From: Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples

  % Gene Expression   % Gene Expression
Gene Name Tumor SCC-PSA1 Gene Name Tumor Nulli-SCC
  (P/R) (U/D)   (P/R) (U/D)
Group A    Group A   
Dusp26   325.2 Egln3   259.9
Hsf2   222.5 Ndufab1   245.4
Pdzk1   212.8 Gpr6   229.6
Sdsl   226.2 Ltbr   212.2
Ndufs6   -203.1 Golga5   -208.5
Sox4   -208.1 Slc15a1   -214.6
Group B    Gpatc3   -236.7
Itgbl1 432.6 -396.1 Dgcr8   -323.3
Kcnmb4 397.0 267.5 Tirap   -364.3
Nkx3-1 375.2 260.0 Group B   
Tmprss2 368.3 373.0 Cask 442.1 -220.5
Cthrc1 334.6 298.7 Stau2 292.9 -201.6
Pdgfc 283.2 -392.8 Bnip3 283.4 217.4
Plaur 259.9 -263.2 Pfkp 239.4 251.0
Hoxb2 239.3 -375.5 Pak6 202.4 -213.8
Col4a5 210.8 -320.7    
Gata2 -276.5 -243.0